Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zang, Y; Beard, RL; Chandraratna, RAS; Kang, JX
   Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells
   CELL DEATH AND DIFFERENTIATION
   
   Y. Zang et al., "Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells", CELL DEAT D, 8(5), 2001, pp. 477-485
2. Wakino, S; Kintscher, U; Kim, S; Jackson, S; Yin, F; Nagpal, S; Chandraratna, RAS; Hsueh, WA; Law, RE
   Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   S. Wakino et al., "Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators", ART THROM V, 21(5), 2001, pp. 746-751
3. Beard, RL; Klein, ES; Standeven, AM; Escobar, M; Chandraratna, RAS
   Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity
   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
   
   R.L. Beard et al., "Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity", BIOORG MED, 11(6), 2001, pp. 765-768
4. Koide, T; Downes, M; Chandraratna, RAS; Blumberg, B; Umesono, K
   Active repression of RAR signaling is required for head formation
   GENES & DEVELOPMENT
   
   T. Koide et al., "Active repression of RAR signaling is required for head formation", GENE DEV, 15(16), 2001, pp. 2111-2121
5. Wang, Q; Lee, D; Sysounthone, V; Chandraratna, RAS; Christakos, S; Korah, R; Wieder, R
   1,25-dihydroxyvitamin D-3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects
   BREAST CANCER RESEARCH AND TREATMENT
   
   Q. Wang et al., "1,25-dihydroxyvitamin D-3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects", BREAST CANC, 67(2), 2001, pp. 157-168
6. Soprano, DR; Gambone, CJ; Sheikh, SN; Gabriel, JL; Chandraratna, RAS; Soprano, KJ; Kochhar, DM
   The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells
   TOXICOLOGY AND APPLIED PHARMACOLOGY
   
   D.R. Soprano et al., "The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells", TOX APPL PH, 174(2), 2001, pp. 153-159
7. Thacher, SM; Vasudevan, J; Tsang, KY; Nagpal, S; Chandraratna, RAS
   New dermatological agents for the treatment of psoriasis
   JOURNAL OF MEDICINAL CHEMISTRY
   
   S.M. Thacher et al., "New dermatological agents for the treatment of psoriasis", J MED CHEM, 44(3), 2001, pp. 281-297
8. Vuligonda, V; Thacher, SM; Chandraratna, RAS
   Enantioselective syntheses of potent retinoid X receptor ligands: Differential biological activities of individual antipodes
   JOURNAL OF MEDICINAL CHEMISTRY
   
   V. Vuligonda et al., "Enantioselective syntheses of potent retinoid X receptor ligands: Differential biological activities of individual antipodes", J MED CHEM, 44(14), 2001, pp. 2298-2303
9. Samuel, W; Kutty, RK; Nagineni, S; Gordon, JS; Prouty, SM; Chandraratna, RAS; Wiggert, B
   Regulation of stearoyl coenzyme a desaturase expression in human retinal pigment epithelial cells by retinoic acid
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   W. Samuel et al., "Regulation of stearoyl coenzyme a desaturase expression in human retinal pigment epithelial cells by retinoic acid", J BIOL CHEM, 276(31), 2001, pp. 28744-28750
10. Dawson, MI; Park, JH; Chen, GQ; Chao, WR; Dousman, L; Waleh, N; Hobbs, PD; Jong, L; Toll, L; Zhang, XK; Gu, J; Agadir, A; Merchant, JL; Bai, LC; Verma, AK; Thacher, SM; Chandraratna, RAS; Shroot, B; Hill, DL
    Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: A potential role for trans-RA-induced ZBP-89 in ODC inhibition
    INTERNATIONAL JOURNAL OF CANCER
    
    M.I. Dawson et al., "Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: A potential role for trans-RA-induced ZBP-89 in ODC inhibition", INT J CANC, 91(1), 2001, pp. 8-21
11. Hammond, LA; Van Krinks, CH; Durham, J; Tomkins, SE; Burnett, RD; Jones, EL; Chandraratna, RAS; Brown, G
    Antagonists of retinoic acid receptors (RARs) are potent growth inhibitorsof prostate carcinoma cells
    BRITISH JOURNAL OF CANCER
    
    L.A. Hammond et al., "Antagonists of retinoic acid receptors (RARs) are potent growth inhibitorsof prostate carcinoma cells", BR J CANC, 85(3), 2001, pp. 453-462
12. Standeven, AM; Thacher, SM; Yuan, YD; Escobar, M; Vuligonda, V; Beard, RL; Chandraratna, RAS
    Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents
    BIOCHEMICAL PHARMACOLOGY
    
    A.M. Standeven et al., "Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents", BIOCH PHARM, 62(11), 2001, pp. 1501-1509
13. Nagpal, S; Ghosn, CR; Chandraratna, RAS
    Identification of nuclear receptor interacting proteins using yeast two-hybrid technology - Applications to drug discovery
    STEROID RECEPTOR METHODS: PROTOCOLS AND ASSAYS
    
    S. Nagpal et al., "Identification of nuclear receptor interacting proteins using yeast two-hybrid technology - Applications to drug discovery", METH MOL B, 176, 2001, pp. 359-376
14. Nagpal, S; Chandraratna, RAS
    Recent developments in receptor-selective retinoids
    CURRENT PHARMACEUTICAL DESIGN
    
    S. Nagpal e R.A.S. Chandraratna, "Recent developments in receptor-selective retinoids", CUR PHARM D, 6(9), 2000, pp. 919-931
15. Thacher, SM; Vasudevan, J; Chandraratna, RAS
    Therapeutic applications for ligands of retinoid receptors
    CURRENT PHARMACEUTICAL DESIGN
    
    S.M. Thacher et al., "Therapeutic applications for ligands of retinoid receptors", CUR PHARM D, 6(1), 2000, pp. 25-58
16. Massaro, GD; Massaro, D; Chan, WY; Clerch, LB; Ghyselinck, N; Chambon, P; Chandraratna, RAS
    Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli
    PHYSIOLOGICAL GENOMICS
    
    G.D. Massaro et al., "Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli", PHYSIOL GEN, 4(1), 2000, pp. 51-57
17. Duvic, M; Helekar, B; Schulz, C; Cho, M; DiSepio, D; Hager, C; DiMao, D; Hazarika, P; Jackson, B; Breuer-McHam, J; Young, J; Clayman, G; Lippman, SM; Chandraratna, RAS; Robinson, NA; Deucher, A; Eckert, RL; Nagpal, S
    Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer
    CLINICAL CANCER RESEARCH
    
    M. Duvic et al., "Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer", CLIN CANC R, 6(8), 2000, pp. 3249-3259
18. Sun, SY; Yue, P; Mao, L; Dawson, MI; Shroot, B; Lamph, WW; Heyman, RA; Chandraratna, RAS; Shudo, K; Hong, WK; Lotan, R
    Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
    CLINICAL CANCER RESEARCH
    
    S.Y. Sun et al., "Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells", CLIN CANC R, 6(4), 2000, pp. 1563-1573
19. Tsonis, PA; Trombley, MT; Rowland, T; Chandraratna, RAS; Del Rio-Tsonis, K
    Role of retinoic acid in lens regeneration
    DEVELOPMENTAL DYNAMICS
    
    P.A. Tsonis et al., "Role of retinoic acid in lens regeneration", DEV DYNAM, 219(4), 2000, pp. 588-593
20. Deucher, A; Nagpal, S; Chandraratna, RAS; Di Sepio, D; Robinson, NA; Dashti, SR; Eckert, RL
    The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    A. Deucher et al., "The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity", INT J ONCOL, 17(6), 2000, pp. 1195-1203
21. Sun, SY; Yue, P; Chandraratna, RAS; Tesfaigzi, Y; Hong, WK; Lotan, R
    Dual mechanisms of action of the retinoid CD437: Nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells
    MOLECULAR PHARMACOLOGY
    
    S.Y. Sun et al., "Dual mechanisms of action of the retinoid CD437: Nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells", MOLEC PHARM, 58(3), 2000, pp. 508-514
22. Tsukada, M; Schroder, M; Roos, TC; Chandraratna, RAS; Reichert, U; Merk, HF; Orfanos, CE; Zouboulis, CC
    13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors
    JOURNAL OF INVESTIGATIVE DERMATOLOGY
    
    M. Tsukada et al., "13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors", J INVES DER, 115(2), 2000, pp. 321-327
23. Weston, AD; Rosen, V; Chandraratna, RAS; Underhill, TM
    Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways
    JOURNAL OF CELL BIOLOGY
    
    A.D. Weston et al., "Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways", J CELL BIOL, 148(4), 2000, pp. 679-690
24. Klein, ES; Wang, JW; Khalifa, B; Gavigan, SA; Chandraratna, RAS
    Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands - Influence of DNA-heterodimer interactions
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    E.S. Klein et al., "Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands - Influence of DNA-heterodimer interactions", J BIOL CHEM, 275(25), 2000, pp. 19401-19408
25. Kintscher, U; Goetze, S; Wakino, S; Kim, S; Nagpal, S; Chandraratna, RAS; Graf, K; Fleck, E; Hsueh, WA; Law, RE
    Peroxisome proliferator-activated receptor and retinoid X receptor ligandsinhibit monocyte chemotactic protein-1-directed migration of monocytes
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    U. Kintscher et al., "Peroxisome proliferator-activated receptor and retinoid X receptor ligandsinhibit monocyte chemotactic protein-1-directed migration of monocytes", EUR J PHARM, 401(3), 2000, pp. 259-270
26. DiSepio, D; Chandraratna, RAS; Nagpal, S
    Novel approaches for the treatment of psoriasis
    DRUG DISCOVERY TODAY
    
    D. DiSepio et al., "Novel approaches for the treatment of psoriasis", DRUG DISC T, 4(5), 1999, pp. 222-231
27. Sun, SY; Kurie, JM; Yue, P; Dawson, MI; Shroot, B; Chandraratna, RAS; Hong, WK; Lotan, R
    Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids
    CLINICAL CANCER RESEARCH
    
    S.Y. Sun et al., "Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids", CLIN CANC R, 5(2), 1999, pp. 431-437
28. Kang, JX; Bell, J; Beard, RL; Chandraratna, RAS
    Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids
    CELL GROWTH & DIFFERENTIATION
    
    J.X. Kang et al., "Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids", CELL GROWTH, 10(8), 1999, pp. 591-600
29. Thacher, SM; Nagpal, S; Klein, ES; Arefieg, T; Krasinski, G; DiSepio, D; Agarwal, C; Johnson, A; Eckert, RL; Chandraratna, RAS
    Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes
    CELL GROWTH & DIFFERENTIATION
    
    S.M. Thacher et al., "Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes", CELL GROWTH, 10(4), 1999, pp. 255-262
30. Johnson, AT; Wang, LM; Standeven, AM; Escobar, M; Chandraratna, RAS
    Synthesis and biological activity of high-affinity retinoic acid receptor antagonists
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    A.T. Johnson et al., "Synthesis and biological activity of high-affinity retinoic acid receptor antagonists", BIO MED CH, 7(7), 1999, pp. 1321-1338
31. Vuligonda, V; Lin, Y; Thacher, SM; Standeven, AM; Kochar, DM; Chandraratna, RAS
    A new class of RAR subtype selective retinoids: Correlation of pharmacological effects with receptor activity
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    V. Vuligonda et al., "A new class of RAR subtype selective retinoids: Correlation of pharmacological effects with receptor activity", BIO MED CH, 7(2), 1999, pp. 263-270
32. Vuligonda, V; Standeven, AM; Escobar, M; Chandraratna, RAS
    A new class of potent RAR antagonists: Dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    V. Vuligonda et al., "A new class of potent RAR antagonists: Dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids", BIOORG MED, 9(5), 1999, pp. 743-748
33. Johnson, AT; Wang, LM; Gillett, SJ; Chandraratna, RAS
    High affinity retinoic acid receptor antagonists: Analogs of AGN 193109
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    A.T. Johnson et al., "High affinity retinoic acid receptor antagonists: Analogs of AGN 193109", BIOORG MED, 9(4), 1999, pp. 573-576
34. Vuligonda, V; Garst, ME; Chandraratna, RAS
    Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    V. Vuligonda et al., "Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands", BIOORG MED, 9(4), 1999, pp. 589-594
35. Vuligonda, V; Chandraratna, RAS
    A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid - A potent retinoic acid receptor antagonist
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    V. Vuligonda e R.A.S. Chandraratna, "A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid - A potent retinoic acid receptor antagonist", BIOORG MED, 9(16), 1999, pp. 2289-2290
36. Johnson, BS; Chandraratna, RAS; Heyman, RA; Allegretto, EA; Mueller, L; Collins, SJ
    Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha 403 heterodimers is developmentally regulated during myeloid differentiation
    MOLECULAR AND CELLULAR BIOLOGY
    
    B.S. Johnson et al., "Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha 403 heterodimers is developmentally regulated during myeloid differentiation", MOL CELL B, 19(5), 1999, pp. 3372-3382
37. Tsukui, T; Capdevila, J; Tamura, K; Ruiz-Lozano, P; Rodriguez-Esteban, C; Yonei-Tamura, S; Magallon, J; Chandraratna, RAS; Chien, K; Blumberg, B; Evans, RM; Belmonte, JCI
    Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the Shh and retinoic acid pathways in the control of Lefty-1
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    T. Tsukui et al., "Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the Shh and retinoic acid pathways in the control of Lefty-1", P NAS US, 96(20), 1999, pp. 11376-11381
38. Nagpal, S; Ghosn, C; DiSepio, D; Molina, Y; Sutter, M; Klein, ES; Chandraratna, RAS
    Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S. Nagpal et al., "Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor", J BIOL CHEM, 274(32), 1999, pp. 22563-22568
39. Koyama, E; Golden, EB; Kirsch, T; Adams, SL; Chandraratna, RAS; Michaille, JJ; Pacifici, M
    Retinoid signaling is required for chondrocyte maturation and endochondralbone formation during limb skeletogenesis
    DEVELOPMENTAL BIOLOGY
    
    E. Koyama et al., "Retinoid signaling is required for chondrocyte maturation and endochondralbone formation during limb skeletogenesis", DEVELOP BIO, 208(2), 1999, pp. 375-391
40. Shalita, AR; Chalker, DK; Griffith, RF; Herbert, AA; Hickman, JG; Maloney, JM; Miller, BH; Tschen, EH; Chandraratna, RAS; Gibson, JR; Lew-Kaya, DA; Lue, JC; Sefton, J
    Tazarotene gel is safe and effective in the treatment of acne vulgaris: A multicenter, double-blind, vehicle-controlled study
    CUTIS
    
    A.R. Shalita et al., "Tazarotene gel is safe and effective in the treatment of acne vulgaris: A multicenter, double-blind, vehicle-controlled study", CUTIS, 63(6), 1999, pp. 349-354
41. Zhu, WY; Jones, CS; Amin, S; Matsukuma, K; Haque, M; Vuligonda, V; Chandraratna, RAS; De Luca, LM
    Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells
    CANCER RESEARCH
    
    W.Y. Zhu et al., "Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells", CANCER RES, 59(1), 1999, pp. 85-90
42. Johnson, A; Chandraratna, RAS
    Novel retinoids with receptor selectivity and functional selectivity
    BRITISH JOURNAL OF DERMATOLOGY
    
    A. Johnson e R.A.S. Chandraratna, "Novel retinoids with receptor selectivity and functional selectivity", BR J DERM, 140, 1999, pp. 12-17
43. Agarwal, C; Lambert, A; Chandraratna, RAS; Rorke, EA; Eckert, RL
    Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level
    BIOLOGY OF REPRODUCTION
    
    C. Agarwal et al., "Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level", BIOL REPROD, 60(3), 1999, pp. 567-572
44. KOCHHAR DM; JIANG H; PENNER JD; JOHNSON AT; CHANDRARATNA RAS
    THE USE OF A RETINOID RECEPTOR ANTAGONIST IN A NEW MODEL TO STUDY VITAMIN-A-DEPENDENT DEVELOPMENTAL EVENTS
    The International journal of developmental biology
    
    D.M. Kochhar et al., "THE USE OF A RETINOID RECEPTOR ANTAGONIST IN A NEW MODEL TO STUDY VITAMIN-A-DEPENDENT DEVELOPMENTAL EVENTS", The International journal of developmental biology, 42(4), 1998, pp. 601-608
45. CHANDRARATNA RAS
    RATIONAL DESIGN OF RECEPTOR-SELECTIVE RETINOIDS
    Journal of the American Academy of Dermatology
    
    R.A.S. Chandraratna, "RATIONAL DESIGN OF RECEPTOR-SELECTIVE RETINOIDS", Journal of the American Academy of Dermatology, 39(4), 1998, pp. 124-128
46. CHANDRARATNA RAS
    FUTURE-TRENDS - A NEW-GENERATION OF RETINOIDS
    Journal of the American Academy of Dermatology
    
    R.A.S. Chandraratna, "FUTURE-TRENDS - A NEW-GENERATION OF RETINOIDS", Journal of the American Academy of Dermatology, 39(4), 1998, pp. 149-152
47. LEBWOHL M; AST E; CALLEN JP; CULLEN SI; HONG SR; KULPSHORTEN CL; LOWE NJ; PHILLIPS TJ; ROSEN T; WOLF DI; QUELL JM; SEFTON J; LUE JC; GIBSON JR; CHANDRARATNA RAS
    ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS
    Journal of the American Academy of Dermatology
    
    M. Lebwohl et al., "ONCE-DAILY TAZAROTENE GEL VERSUS TWICE-DAILY FLUOCINONIDE CREAM IN THE TREATMENT OF PLAQUE PSORIASIS", Journal of the American Academy of Dermatology, 38(5), 1998, pp. 705-711
48. KANG JX; BELL J; LEAF A; BEARD RL; CHANDRARATNA RAS
    RETINOIC ACID ALTERS THE INTRACELLULAR TRAFFICKING OF THE MANNOSE-6-PHOSPHATE INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR AND LYSOSOMAL-ENZYMES
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    J.X. Kang et al., "RETINOIC ACID ALTERS THE INTRACELLULAR TRAFFICKING OF THE MANNOSE-6-PHOSPHATE INSULIN-LIKE-GROWTH-FACTOR-II RECEPTOR AND LYSOSOMAL-ENZYMES", Proceedings of the National Academy of Sciences of the United Statesof America, 95(23), 1998, pp. 13687-13691
49. DiSepio, D; Ghosn, C; Eckert, RL; Deucher, A; Robinson, N; Duvic, M; Chandraratna, RAS; Nagpal, S
    Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    D. DiSepio et al., "Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene", P NAS US, 95(25), 1998, pp. 14811-14815
50. ANGULO A; CHANDRARATNA RAS; LEBLANC JF; GHAZAL P
    LIGAND INDUCTION OF RETINOIC ACID RECEPTORS ALTERS AN ACUTE INFECTIONBY MURINE CYTOMEGALOVIRUS
    Journal of virology
    
    A. Angulo et al., "LIGAND INDUCTION OF RETINOIC ACID RECEPTORS ALTERS AN ACUTE INFECTIONBY MURINE CYTOMEGALOVIRUS", Journal of virology, 72(6), 1998, pp. 4589-4600
51. KRUEGER GG; DRAKE LA; ELIAS PM; LOWE NJ; GUZZO C; WEINSTEIN GD; LEWKAYA DA; LUE JC; SEFTON J; CHANDRARATNA RAS
    THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS
    Archives of dermatology
    
    G.G. Krueger et al., "THE SAFETY AND EFFICACY OF TAZAROTENE GEL, A TOPICAL ACETYLENIC RETINOID, IN THE TREATMENT OF PSORIASIS", Archives of dermatology, 134(1), 1998, pp. 57-60
52. BEARD RL; TENG M; COLON DF; DUONG TT; THACHER SM; AREFIEG T; CHANDRARATNA RAS
    SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,3,4-TETRAHYDROQUINOLINE AND 3,4-(1H)-DIHYDROQUINOLIN-2-ONE ANALOGS OF RETINOIC ACID
    Bioorganic & medicinal chemistry letters
    
    R.L. Beard et al., "SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,3,4-TETRAHYDROQUINOLINE AND 3,4-(1H)-DIHYDROQUINOLIN-2-ONE ANALOGS OF RETINOIC ACID", Bioorganic & medicinal chemistry letters, 7(18), 1997, pp. 2373-2378
53. STANDEVEN AM; TENG M; CHANDRARATNA RAS
    LACK OF INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA IN RETINOID-INDUCED SKIN IRRITATION IN HAIRLESS MICE
    Toxicology letters
    
    A.M. Standeven et al., "LACK OF INVOLVEMENT OF RETINOIC ACID RECEPTOR-ALPHA IN RETINOID-INDUCED SKIN IRRITATION IN HAIRLESS MICE", Toxicology letters, 92(3), 1997, pp. 231-240
54. NAGPAL S; CAI J; ZHENG T; PATEL S; MASOOD R; LIN GY; FRIANT S; JOHNSON A; SMITH DL; CHANDRARATNA RAS; GILL PS
    RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA
    Molecular and cellular biology
    
    S. Nagpal et al., "RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA", Molecular and cellular biology, 17(7), 1997, pp. 4159-4168
55. CHANDRARATNA RAS
    TAZAROTENE - THE FIRST RECEPTOR-SELECTIVE TOPICAL RETINOID FOR THE TREATMENT OF PSORIASIS
    Journal of the American Academy of Dermatology
    
    R.A.S. Chandraratna, "TAZAROTENE - THE FIRST RECEPTOR-SELECTIVE TOPICAL RETINOID FOR THE TREATMENT OF PSORIASIS", Journal of the American Academy of Dermatology, 37(2), 1997, pp. 12-17
56. DUVIC M; NAGPAL S; ASANO AT; CHANDRARATNA RAS
    MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS
    Journal of the American Academy of Dermatology
    
    M. Duvic et al., "MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS", Journal of the American Academy of Dermatology, 37(2), 1997, pp. 18-24
57. WEINSTEIN GD; KRUEGER GG; LOWE NJ; DUVIC M; FRIEDMAN DJ; JEGASOTHY BV; JORIZZO JL; SHMUNES E; TSCHEN EH; LEWKAYA DA; LUE JC; SEFTON J; GIBSON JR; CHANDRARATNA RAS
    TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT
    Journal of the American Academy of Dermatology
    
    G.D. Weinstein et al., "TAZAROTENE GEL, A NEW RETINOID, FOR TOPICAL THERAPY OF PSORIASIS - VEHICLE-CONTROLLED STUDY OF SAFETY, EFFICACY, AND DURATION OF THERAPEUTIC EFFECT", Journal of the American Academy of Dermatology, 37(1), 1997, pp. 85-92
58. THACHER SM; STANDEVEN AM; ATHANIKAR J; KOPPER S; CASTILLEJA O; ESCOBAR M; BEARD RL; CHANDRARATNA RAS
    RECEPTOR SPECIFICITY OF RETINOID-INDUCED EPIDERMAL HYPERPLASIA - EFFECT OF RXR-SELECTIVE AGONISTS AND CORRELATION WITH TOPICAL IRRITATION
    The Journal of pharmacology and experimental therapeutics
    
    S.M. Thacher et al., "RECEPTOR SPECIFICITY OF RETINOID-INDUCED EPIDERMAL HYPERPLASIA - EFFECT OF RXR-SELECTIVE AGONISTS AND CORRELATION WITH TOPICAL IRRITATION", The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 528-534
59. TENG M; DUONG TT; JOHNSON AT; KLEIN ES; WANG LM; KHALIFA B; CHANDRARATNA RAS
    IDENTIFICATION OF HIGHLY POTENT RETINOIC ACID RECEPTOR ALPHA-SELECTIVE ANTAGONISTS
    Journal of medicinal chemistry
    
    M. Teng et al., "IDENTIFICATION OF HIGHLY POTENT RETINOIC ACID RECEPTOR ALPHA-SELECTIVE ANTAGONISTS", Journal of medicinal chemistry, 40(16), 1997, pp. 2445-2451
60. NAGPAL S; PATEL S; JACOBE H; DISEPIO D; GHOSN C; MALHOTRA M; TENG M; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN", Journal of investigative dermatology, 109(1), 1997, pp. 91-95
61. HAZARIKA P; DUONG DMT; HAGER C; HAKINZADEH M; SARRIS A; NAGPAL S; THACHER S; CHANDRARATNA RAS; DUVIC M
    INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES
    Journal of investigative dermatology
    
    P. Hazarika et al., "INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES", Journal of investigative dermatology, 108(4), 1997, pp. 204-204
62. NAGPAL S; GHOSN C; DISEPIO D; MALHOTRA M; PATEL S; JACOBE H; HAGER C; THACHER S; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION", Journal of investigative dermatology, 108(4), 1997, pp. 245-245
63. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
    RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION
    Journal of investigative dermatology
    
    D. Disepio et al., "RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION", Journal of investigative dermatology, 108(4), 1997, pp. 246-246
64. KLEIN ES; PINO ME; JOHNSON AT; NAGPAL S; THACHER S; KRASINSKI G; CHANDRARATNA RAS
    IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS
    Journal of investigative dermatology
    
    E.S. Klein et al., "IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS", Journal of investigative dermatology, 108(4), 1997, pp. 249-249
65. AGARWAL C; CHANDRARATNA RAS; RORKE EA; ECKERT RL
    VITAMIN-D SUPPRESSES HUMAN ECTOCERVICAL KERATINOCYTE PROLIFERATION AND INCREASES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3)
    Journal of investigative dermatology
    
    C. Agarwal et al., "VITAMIN-D SUPPRESSES HUMAN ECTOCERVICAL KERATINOCYTE PROLIFERATION AND INCREASES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3)", Journal of investigative dermatology, 108(4), 1997, pp. 252-252
66. NAGPAL S; DISEPIO D; MALHOTRA M; GHOSN C; DUVIC M; CHANDRARATNA RAS
    ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS
    Journal of investigative dermatology
    
    S. Nagpal et al., "ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS", Journal of investigative dermatology, 108(4), 1997, pp. 297-297
67. HEMBREE JR; AGARWAL C; EFIMOVA T; CHANDRARATNA RAS; ECKERT RL
    INTERFERON REGULATION OF PROLIFERATION AND INSULIN-LIKE GROWTH-FACTORBINDING-PROTEIN EXPRESSION IN HUMAN ECTOCERVICAL KERATINOCYTES
    Journal of investigative dermatology
    
    J.R. Hembree et al., "INTERFERON REGULATION OF PROLIFERATION AND INSULIN-LIKE GROWTH-FACTORBINDING-PROTEIN EXPRESSION IN HUMAN ECTOCERVICAL KERATINOCYTES", Journal of investigative dermatology, 108(4), 1997, pp. 483-483
68. HAGER C; DIMAIO D; MAYS S; ANGEL T; CUNNINGHAM MA; LEDBETTER L; SEFTON J; THACHER SM; NAGPAL S; CHANDRARATNA RAS; DUVIC M
    TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES
    Journal of investigative dermatology
    
    C. Hager et al., "TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES", Journal of investigative dermatology, 108(4), 1997, pp. 712-712
69. CHANDRARATNA RAS; THACHER SM; KLEIN ES
    RETINOID AGONISTS AND INVERSE AGONISTS - A NEW-GENERATION
    Journal of investigative dermatology
    
    R.A.S. Chandraratna et al., "RETINOID AGONISTS AND INVERSE AGONISTS - A NEW-GENERATION", Journal of investigative dermatology, 108(3), 1997, pp. 114-114
70. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
    RETINOIC ACID RECEPTOR-NUCLEAR FACTOR-INTERLEUKIN-6 ANTAGONISM - A NOVEL MECHANISM OF RETINOID-DEPENDENT INHIBITION OF A KERATINOCYTE HYPERPROLIFERATIVE DIFFERENTIATION MARKER
    The Journal of biological chemistry
    
    D. Disepio et al., "RETINOIC ACID RECEPTOR-NUCLEAR FACTOR-INTERLEUKIN-6 ANTAGONISM - A NOVEL MECHANISM OF RETINOID-DEPENDENT INHIBITION OF A KERATINOCYTE HYPERPROLIFERATIVE DIFFERENTIATION MARKER", The Journal of biological chemistry, 272(41), 1997, pp. 25555-25559
71. SUN SY; YUE P; DAWSON MI; SHROOT B; MICHEL S; LAMPH WW; HEYMAN RA; TENG M; CHANDRARATNA RAS; SHUDO K; HONG WK; LOTAN R
    DIFFERENTIAL-EFFECTS OF SYNTHETIC NUCLEAR RETINOID RECEPTOR-SELECTIVERETINOIDS ON THE GROWTH OF HUMAN NONSMALL CELL LUNG-CARCINOMA CELLS
    Cancer research
    
    S.Y. Sun et al., "DIFFERENTIAL-EFFECTS OF SYNTHETIC NUCLEAR RETINOID RECEPTOR-SELECTIVERETINOIDS ON THE GROWTH OF HUMAN NONSMALL CELL LUNG-CARCINOMA CELLS", Cancer research, 57(21), 1997, pp. 4931-4939
72. FITZGERALD P; TENG M; CHANDRARATNA RAS; HEYMAN RA; ALLEGRETTO EA
    RETINOIC ACID RECEPTOR-ALPHA EXPRESSION CORRELATES WITH RETINOID-INDUCED GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS REGARDLESS OF ESTROGEN-RECEPTOR STATUS
    Cancer research
    
    P. Fitzgerald et al., "RETINOIC ACID RECEPTOR-ALPHA EXPRESSION CORRELATES WITH RETINOID-INDUCED GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS REGARDLESS OF ESTROGEN-RECEPTOR STATUS", Cancer research, 57(13), 1997, pp. 2642-2650
73. STANDEVEN AM; ESCOBAR M; BEARD RL; YUAN YD; CHANDRARATNA RAS
    MITOGENIC EFFECT OF RETINOID-X-RECEPTOR AGONISTS IN RAT-LIVER
    Biochemical pharmacology
    
    A.M. Standeven et al., "MITOGENIC EFFECT OF RETINOID-X-RECEPTOR AGONISTS IN RAT-LIVER", Biochemical pharmacology, 54(4), 1997, pp. 517-524
74. AGARWAL C; CHANDRARATNA RAS; TENG M; NAGPAL S; RORKE EA; ECKERT RL
    DIFFERENTIAL REGULATION OF HUMAN ECTOCERVICAL EPITHELIAL-CELL LINE PROLIFERATION AND DIFFERENTIATION BY RETINOID-X-RECEPTOR-SPECIFIC AND RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS
    Cell growth & differentiation
    
    C. Agarwal et al., "DIFFERENTIAL REGULATION OF HUMAN ECTOCERVICAL EPITHELIAL-CELL LINE PROLIFERATION AND DIFFERENTIATION BY RETINOID-X-RECEPTOR-SPECIFIC AND RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS", Cell growth & differentiation, 7(4), 1996, pp. 521-530
75. NAGPAL S; THACHER SM; PATEL S; FRIANT S; MALHOTRA M; SHAFER J; KRASINSKI G; ASANO AT; TENG M; DUVIC M; CHANDRARATNA RAS
    NEGATIVE REGULATION OF 2 HYPERPROLIFERATIVE KERATINOCYTE DIFFERENTIATION MARKERS BY A RETINOIC ACID RECEPTOR-SPECIFIC RETINOID - INSIGHT INTO THE MECHANISM OF RETINOID ACTION IN PSORIASIS
    Cell growth & differentiation
    
    S. Nagpal et al., "NEGATIVE REGULATION OF 2 HYPERPROLIFERATIVE KERATINOCYTE DIFFERENTIATION MARKERS BY A RETINOIC ACID RECEPTOR-SPECIFIC RETINOID - INSIGHT INTO THE MECHANISM OF RETINOID ACTION IN PSORIASIS", Cell growth & differentiation, 7(12), 1996, pp. 1783-1791
76. VULIGONDA V; LIN Y; CHANDRARATNA RAS
    SYNTHESIS OF HIGHLY POTENT RXR-SPECIFIC RETINOIDS - THE USE OF A CYCLOPROPYL GROUP AS A DOUBLE-BOND ISOSTERE
    Bioorganic & medicinal chemistry letters
    
    V. Vuligonda et al., "SYNTHESIS OF HIGHLY POTENT RXR-SPECIFIC RETINOIDS - THE USE OF A CYCLOPROPYL GROUP AS A DOUBLE-BOND ISOSTERE", Bioorganic & medicinal chemistry letters, 6(2), 1996, pp. 213-218
77. STANDEVEN AM; DAVIES PJA; CHANDRARATNA RAS; MADER DR; JOHNSON AT; THOMAZY VA
    RETINOID-INDUCED EPIPHYSEAL PLATE CLOSURE IN GUINEA-PIGS
    Fundamental and applied toxicology
    
    A.M. Standeven et al., "RETINOID-INDUCED EPIPHYSEAL PLATE CLOSURE IN GUINEA-PIGS", Fundamental and applied toxicology, 34(1), 1996, pp. 91-98
78. STANDEVEN AM; BEARD RL; JOHNSON AT; BOEHM MF; ESCOBAR M; HEYMAN RA; CHANDRARATNA RAS
    RETINOID-INDUCED HYPERTRIGLYCERIDEMIA IN RATS IS MEDIATED BY RETINOICACID RECEPTORS
    Fundamental and applied toxicology
    
    A.M. Standeven et al., "RETINOID-INDUCED HYPERTRIGLYCERIDEMIA IN RATS IS MEDIATED BY RETINOICACID RECEPTORS", Fundamental and applied toxicology, 33(2), 1996, pp. 264-271
79. NAGY L; THOMAZY VA; CHANDRARATNA RAS; HEYMAN RA; DAVIES PJA
    RETINOID-REGULATED EXPRESSION OF BCL-2 AND TISSUE TRANSGLUTAMINASE DURING THE DIFFERENTIATION AND APOPTOSIS OF HUMAN MYELOID-LEUKEMIA (HL-60) CELLS
    Leukemia research
    
    L. Nagy et al., "RETINOID-REGULATED EXPRESSION OF BCL-2 AND TISSUE TRANSGLUTAMINASE DURING THE DIFFERENTIATION AND APOPTOSIS OF HUMAN MYELOID-LEUKEMIA (HL-60) CELLS", Leukemia research, 20(6), 1996, pp. 499-505
80. STANDEVEN AM; JOHNSON AT; ESCOBAR R; CHANDRARATNA RAS
    SPECIFIC ANTAGONIST OF RETINOID TOXICITY IN MICE
    Toxicology and applied pharmacology
    
    A.M. Standeven et al., "SPECIFIC ANTAGONIST OF RETINOID TOXICITY IN MICE", Toxicology and applied pharmacology, 138(1), 1996, pp. 169-175
81. VULIGONDA V; LIN Y; CHANDRARATNA RAS
    SELECTIVE CONVERSION OF ALPHA-TETRALONES TO DIHYDRONAPHTHALENES
    Tetrahedron letters
    
    V. Vuligonda et al., "SELECTIVE CONVERSION OF ALPHA-TETRALONES TO DIHYDRONAPHTHALENES", Tetrahedron letters, 37(12), 1996, pp. 1941-1944
82. JOHNSON AT; KLEIN ES; WANG LM; PINO ME; CHANDRARATNA RAS
    IDENTIFICATION OF RETINOIC ACID RECEPTOR-BETA SUBTYPE-SPECIFIC AGONISTS
    Journal of medicinal chemistry
    
    A.T. Johnson et al., "IDENTIFICATION OF RETINOIC ACID RECEPTOR-BETA SUBTYPE-SPECIFIC AGONISTS", Journal of medicinal chemistry, 39(26), 1996, pp. 5027-5030
83. BEARD RL; COLON DF; SONG TK; DAVIES PJA; KOCHHAR DM; CHANDRARATNA RAS
    SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF RETINOID-X RECEPTOR-SELECTIVE DIARYL SULFIDE ANALOGS OF RETINOIC ACID
    Journal of medicinal chemistry
    
    R.L. Beard et al., "SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF RETINOID-X RECEPTOR-SELECTIVE DIARYL SULFIDE ANALOGS OF RETINOIC ACID", Journal of medicinal chemistry, 39(18), 1996, pp. 3556-3563
84. TENG M; DUONG TT; KLEIN ES; PINO ME; CHANDRARATNA RAS
    IDENTIFICATION OF A RETINOIC ACID RECEPTOR-ALPHA SUBTYPE-SPECIFIC AGONIST
    Journal of medicinal chemistry
    
    M. Teng et al., "IDENTIFICATION OF A RETINOIC ACID RECEPTOR-ALPHA SUBTYPE-SPECIFIC AGONIST", Journal of medicinal chemistry, 39(16), 1996, pp. 3035-3038
85. NAGPAL S; PATEL S; ASANO AT; JOHNSON A; DUVIC M; CHANDRARATNA RAS
    TIG1 AND TIG2 (TAZAROTENE INDUCED GENE-1 AND GENE-2) ARE NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENES IN SKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TIG1 AND TIG2 (TAZAROTENE INDUCED GENE-1 AND GENE-2) ARE NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENES IN SKIN", Journal of investigative dermatology, 106(4), 1996, pp. 78-78
86. AGARWAL C; CHANDRARATNA RAS; JOHNSON AT; RORKE EA; ECKERT RL
    AGN193109 IS A PURE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL KERATINOCYTES
    Journal of investigative dermatology
    
    C. Agarwal et al., "AGN193109 IS A PURE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL KERATINOCYTES", Journal of investigative dermatology, 106(4), 1996, pp. 79-79
87. HEMBREE JR; AGARWAL C; BAARD RL; CHANDRARATNA RAS; ECKERT RL
    RXR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RAR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-9 (IGFBP-3) IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS
    Journal of investigative dermatology
    
    J.R. Hembree et al., "RXR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RAR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-9 (IGFBP-3) IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS", Journal of investigative dermatology, 106(4), 1996, pp. 81-81
88. THACHER SM; KRASINSKI G; MALHOTRA M; DUVIC M; NAGPAL S; CHANDRARATNA RAS
    COORDINATE REGULATION OF KERATINOCYTE DIFFERENTIATION MARKERS BY RETINOIDS IN CELL-CULTURE AND IN PSORIASIS
    Journal of investigative dermatology
    
    S.M. Thacher et al., "COORDINATE REGULATION OF KERATINOCYTE DIFFERENTIATION MARKERS BY RETINOIDS IN CELL-CULTURE AND IN PSORIASIS", Journal of investigative dermatology, 106(4), 1996, pp. 82-82
89. CHANDRARATNA RAS; KLEIN ES; JOHNSON AT; ESCOBAR M; STANDEVEN AM
    THE USE OF A RETINOIC ACID RECEPTOR ANTAGONIST TO PREVENT RETINOID-INDUCED SKIN IRRITATION
    Journal of investigative dermatology
    
    R.A.S. Chandraratna et al., "THE USE OF A RETINOIC ACID RECEPTOR ANTAGONIST TO PREVENT RETINOID-INDUCED SKIN IRRITATION", Journal of investigative dermatology, 106(4), 1996, pp. 242-242
90. NAGPAL S; PATEL S; ASANO AT; JOHNSON AT; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE-INDUCED GENE-1 (TIG1), A NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENE IN SKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE-INDUCED GENE-1 (TIG1), A NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENE IN SKIN", Journal of investigative dermatology, 106(2), 1996, pp. 269-274
91. NAGY L; SAYDAK M; SHIPLEY N; LU S; BASILION JP; YAN ZH; SYKA P; CHANDRARATNA RAS; STEIN JP; HEYMAN RA; DAVIES PJA
    IDENTIFICATION AND CHARACTERIZATION OF A VERSATILE RETINOID RESPONSE ELEMENT (RETINOIC ACID RECEPTOR RESPONSE ELEMENT-RETINOID-X-RECEPTOR RESPONSE ELEMENT) IN THE MOUSE-TISSUE TRANSGLUTAMINASE GENE PROMOTER
    The Journal of biological chemistry
    
    L. Nagy et al., "IDENTIFICATION AND CHARACTERIZATION OF A VERSATILE RETINOID RESPONSE ELEMENT (RETINOIC ACID RECEPTOR RESPONSE ELEMENT-RETINOID-X-RECEPTOR RESPONSE ELEMENT) IN THE MOUSE-TISSUE TRANSGLUTAMINASE GENE PROMOTER", The Journal of biological chemistry, 271(8), 1996, pp. 4355-4365
92. AGARWAL C; CHANDRARATNA RAS; JOHNSON AT; RORKE EA; ECKERT RL
    AGN193109 IS A HIGHLY EFFECTIVE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS
    The Journal of biological chemistry
    
    C. Agarwal et al., "AGN193109 IS A HIGHLY EFFECTIVE ANTAGONIST OF RETINOID ACTION IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS", The Journal of biological chemistry, 271(21), 1996, pp. 12209-12212
93. KOCHHAR DM; JIANG H; PENNERA JD; BEARD RL; CHANDRARATNA RAS
    DIFFERENTIAL TERATOGENIC RESPONSE OF MOUSE EMBRYOS TO RECEPTOR-SELECTIVE ANALOGS OF RETINOIC ACID
    Chemico-biological interactions
    
    D.M. Kochhar et al., "DIFFERENTIAL TERATOGENIC RESPONSE OF MOUSE EMBRYOS TO RECEPTOR-SELECTIVE ANALOGS OF RETINOIC ACID", Chemico-biological interactions, 100(1), 1996, pp. 1-12
94. HEMBREE JR; AGARWAL C; BEARD RL; CHANDRARATNA RAS; ECKERT RL
    RETINOID-X RECEPTOR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS
    Cancer research
    
    J.R. Hembree et al., "RETINOID-X RECEPTOR-SPECIFIC RETINOIDS INHIBIT THE ABILITY OF RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS TO INCREASE THE LEVEL OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN HUMAN ECTOCERVICAL EPITHELIAL-CELLS", Cancer research, 56(8), 1996, pp. 1794-1799
95. CHANDRARATNA RAS
    TAZAROTENE - FIRST OF A NEW-GENERATION OF RECEPTOR-SELECTIVE RETINOIDS
    British journal of dermatology
    
    R.A.S. Chandraratna, "TAZAROTENE - FIRST OF A NEW-GENERATION OF RECEPTOR-SELECTIVE RETINOIDS", British journal of dermatology, 135, 1996, pp. 18-25
96. KOCHHAR DM; JIANG H; PENNER JD; JOHNSON AP; CHANDRARATNA RAS
    INDISPENSABLE ROLE OF VITAMIN-A SIGNALING IN NORMAL VERTEBRATE DEVELOPMENT
    Molecular biology of the cell
    
    D.M. Kochhar et al., "INDISPENSABLE ROLE OF VITAMIN-A SIGNALING IN NORMAL VERTEBRATE DEVELOPMENT", Molecular biology of the cell, 6, 1995, pp. 1875-1875
97. CHANDRARATNA RAS; GILLETT SJ; SONG TK; ATTARD J; VULIGONDA S; GARST ME; AREFIEG T; GIL DW; WHEELER L
    SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF CONFORMATIONALLY RESTRICTED, ACETYLENIC RETINOID ANALOGS
    Bioorganic & medicinal chemistry letters
    
    R.A.S. Chandraratna et al., "SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF CONFORMATIONALLY RESTRICTED, ACETYLENIC RETINOID ANALOGS", Bioorganic & medicinal chemistry letters, 5(5), 1995, pp. 523-527
98. BEARD RL; COLON DF; KLEIN ES; VORSE KA; CHANDRARATNA RAS
    DIFFERENTIAL RXR AND RAR ACTIVITY OF STILBENE RETINOID ANALOGS BEARING THIAZOLE AND IMIDAZOLE CARBOXYLIC-ACIDS
    Bioorganic & medicinal chemistry letters
    
    R.L. Beard et al., "DIFFERENTIAL RXR AND RAR ACTIVITY OF STILBENE RETINOID ANALOGS BEARING THIAZOLE AND IMIDAZOLE CARBOXYLIC-ACIDS", Bioorganic & medicinal chemistry letters, 5(22), 1995, pp. 2729-2734
99. NAGY L; THOMAZY VA; SHIPLEY GL; FESUS L; LAMPH W; HEYMAN RA; CHANDRARATNA RAS; DAVIES PJA
    ACTIVATION OF RETINOID-X RECEPTORS INDUCES APOPTOSIS IN HL-60 CELL-LINES
    Molecular and cellular biology
    
    L. Nagy et al., "ACTIVATION OF RETINOID-X RECEPTORS INDUCES APOPTOSIS IN HL-60 CELL-LINES", Molecular and cellular biology, 15(7), 1995, pp. 3540-3551
100. CHANDRARATNA RAS; HENRY E; ATTARD J; GILLETT SJ; SONG T; GARST ME; NAGPAL S; ATHANIKAR J; AREFIEG T; GIL DW; WHEELER LA; LEWKAYA D; SEFTON J
     DEVELOPMENT OF RAR SUBTYPE-SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES
     European journal of medicinal chemistry
     
     R.A.S. Chandraratna et al., "DEVELOPMENT OF RAR SUBTYPE-SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES", European journal of medicinal chemistry, 30, 1995, pp. 505-517